Table 3.

Outcome measures in patients of rheumatoid arthritis treated with diclofenac, meloxicam, and celecoxib

	Diclofenac (n=10)		Meloxicam (n=10)		Celecoxib (n=10)
	Baseline	Final	Baseline	Final	Baseline	Final
Tender joints count (n)	33.8±1.93	23.4±1.87*	33.3±2.06	22.4±1.26*	31.5±1.77	20.8±1.27*
Change (%)#		30		32		33.80
Swollen joints count (n)	23.2±1.19	14.7±0.59*	21.8±1.70	15.4±1.10*	20.8±1.67	13.2±0.79*
Change (%)#		36		28.20		34.10
Patient assessment of pain (VAS)ª	61.5±3.73	38.9±2.08*,$	64.5±3.08	42.1±2.51*	66.4±3.41	47.2±2.68*
Change (%)#		35		34.50		27.70
Physician global assessment (VAS)ª	51.4±3.26	32.4±1.68*,$	51.3±1.28	34.7±2.20*	57.8±2.41	41.2±2.44*
Change (%)#		34.60		32.20		27.80
Patient global assessment (VAS)ª	53.8±3.46	36.8±2.05*,$	58.0±3.27	38.5±2.62*	60.4±3.12	43.8±2.11*
Change (%)#		30.70		32.40		26.20
Patient assessment of physical function on modified MHAQ§	17.4±1.93	12.7±0.63*	17.3±1.14	12.1±0.48*	16.3±0.83	11.9±0.46*
Change (%)#		25.30		28.20		25.80

ªScore of 0 is best, 10 is worst; ^§Score of 8 is best, 32 is worst; ^#Based on mean values; *P<0.001 baseline versus final values in corresponding treatment groups; ^$P<0.05 versus celecoxib group at end of week 12. All values expressed as mean±SE. VAS: Visual analog scale (mm); MHAQ: Modified health assessment questionnaire; SE: Standard error